University of Pittsburgh launches institute linking space research to global health

The University of Pittsburgh Health Sciences has announced a new institute that applies lessons from spaceflight to healthcare on Earth, bringing astronaut-led research into genomics, AI, and low-resource medicine under one roof.

The University of Pittsburgh Health Sciences today announced the launch of the Trivedi Institute for Space and Global Biomedicine, a $25 million research initiative designed to translate insights from spaceflight into advances in human health on Earth.

The University of Pittsburgh Health Sciences today announced the launch of the Trivedi Institute for Space and Global Biomedicine, a $25 million research initiative designed to translate insights from spaceflight into advances in human health on Earth. The move signals growing interest in space-enabled biomedical research with implications for healthcare delivery, education, and workforce development across science and medicine.

Leadership and scope set early direction

The institute will be led by Kate Rubins, Professor of Computational and Systems Biology at the University of Pittsburgh Health Sciences, following a 16-year career as a NASA Astronaut that included two long-duration missions and a total of 300 days in space. Rubins was the first person to sequence DNA in space and led multiple investigations into genomics and human health under extreme conditions.

Rubins says: “Technologies developed for use in the severely resource-constrained circumstances of space travel can be repurposed for use in patients on Earth. These approaches are particularly powerful in settings with limited infrastructure, including disaster response, rural medicine, military operations and humanitarian missions.”

The institute’s primary funding comes from the Trivedi Family Foundation, led by Pittsburgh-based entrepreneur, investor, and philanthropist Ashok Trivedi, who is supporting research that bridges biomedical science on Earth with the demands of human spaceflight.

Trivedi says: “By investing in science that improves quality of life—from fighting disease and discovering cures for terminal illness to understanding aging and preparing astronauts for the demands of space—the institute can have an impact on all of humanity.”

Accelerating biomedical discovery through extreme environments

University leaders positioned the institute as a strategic extension of Pittsburgh’s existing biomedical research strengths, with space environments offering faster insights into disease progression, cell growth, and biological stress.

Anantha Shekhar, Senior Vice Chancellor for the Health Sciences and John and Gertrude Petersen Dean, School of Medicine, says: “Microgravity and radiation speed up processes like cell growth and disease progression, offering accelerated insights that could cut years off the discovery of major scientific breakthroughs. The harsh environment of space is also a prime testing ground for how to advance human health in low-resourced communities here on Earth, a key strategic goal of Pitt Health Sciences.”

Joan Gabel, Chancellor at the University of Pittsburgh, says: “Pitt is an institution defined by pushing boundaries. And through the new Trivedi Institute for Space and Global Biomedicine, we proudly add to this long-standing distinction at the intersection of space, health and possibilities.”

Partnerships and training into the 2030s

The institute brings together expertise across physics, medicine, synthetic biology, engineering, and data science, with key leadership from Afshin Beheshti, Professor of Surgery and Director, Center for Space Biomedicine, and Sylvain Costes, Professor of Radiation Oncology and Director, Center for Space Biomanufacturing, Synthetic Biology and Digital Health.

Collaboration is central to the model. The institute will work with Carnegie Mellon University, other universities, space agencies, nonprofits, and industry partners to create a cross-institutional research and training ecosystem extending into the 2030s.

Theresa Mayer, Vice President for Research at Carnegie Mellon University, says: “Carnegie Mellon University is thrilled to partner with Pitt on this new institute, which represents an important step forward in advancing human health. We see tremendous opportunity to leverage our complementary strengths in AI, computation and technology innovation to help drive new biological insight and medical innovation.”

ETIH Innovation Awards 2026

The ETIH Innovation Awards 2026 recognize evidence-led innovation across K–12, higher education, and lifelong learning, spanning regions including North America, Europe, and emerging global markets. Entries are open and assessed on demonstrated impact, scalability, and measurable outcomes across education and workforce development.